Cargando…
Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high‐risk multiple myeloma
A second bone marrow aspiration and biopsy showed pure red cell aplasia in this case.[Image: see text]
Autores principales: | Jin, Xianghong, Jiang, Xianyong, Wang, Wei, Liu, Shuangjiao, Han, Bing, Han, Jianhua, Zhuang, Junling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617308/ https://www.ncbi.nlm.nih.gov/pubmed/37915388 http://dx.doi.org/10.1002/cdt3.81 |
Ejemplares similares
-
Effective treatment of refractory acquired pure red blood
cell aplasia with eltrombopag and sirolimus: a case
report
por: Huang, Yuzhou, et al.
Publicado: (2020) -
Sirolimus versus cyclosporine A in patients with primary acquired pure red cell aplasia: a prospective cohort study
por: Yang, Yuan, et al.
Publicado: (2023) -
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide
por: Ito, Tomoki, et al.
Publicado: (2018) -
Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004) -
Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)